New lignan derivatives with isochroman fragments from hawthorn and their preparation and application
By isolating and purifying the enantiomers of new lignans from hawthorn, the problem of extracting neuroprotective active compounds in the prior art has been solved, and significant neuroprotective effects have been achieved.
Patent Information
- Application Number
- CN202310468164.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-04-26
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2043-04-26
AI Technical Summary
Existing technologies make it difficult to effectively extract compounds with neuroprotective activity from natural drugs for the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's.
Four pairs of neolignan enantiomers were isolated and purified from hawthorn (Crataegus pinnatifida), a plant in the genus Crataegus of the Rosaceae family. Optically pure compounds with defined stereoconfigurations were obtained by multi-step chromatography and chiral resolution.
The newly obtained lignan derivatives exhibit significant neuroprotective activity, superior to existing drugs, and have potential for clinical application.
Smart Images

Figure CN116514762B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of medical technology, and specifically relates to four pairs of new lignan derivatives with isochroman fragments extracted and separated from hawthorn and their application in preparing neuroprotective drugs. Background Art
[0002] Hawthorn (Crataegus pinnatifida): It is the dried mature fruit of the plant Crataegus pinnatifida or Crataegus pinnatifida of the Rosaceae family. It tastes sour and sweet, and has multiple effects such as anti-oxidation, lowering blood lipids, lowering blood sugar, and anti-inflammatory. It is also a good medicine for digestion and stomach, promoting qi and dispersing blood stasis, and promoting blood circulation and resolving phlegm. It is a unique Chinese medicine that can be used as both medicine and food. It has a good effect on symptoms such as stomach distension, diarrhea, abdominal pain, blood stasis and amenorrhea.
[0003] Neurodegenerative diseases: a central nervous system disease based on progressive degeneration and necrosis of neurons, characterized by the death of neurons in specific areas of the brain or spinal cord, which can lead to cognitive disorders such as dementia. With the intensification of the global aging trend, the incidence of neurodegenerative diseases including Alzheimer's disease and Parkinson's disease is on the rise, which has seriously increased the economic pressure and medical burden on society. Therefore, it is of great significance to find compounds with neuroprotective activity from natural medicines. Summary of the invention
[0004] The present invention provides four pairs of neolignan enantiomers separated from Crataegus pinnatifida, a plant of the genus Hawthorn in the Rosaceae family. The structures are shown below:
[0005]
[0006] The preparation method of the new lignan derivatives of the present invention comprises the following steps:
[0007] (1) Dried hawthorn fruit was extracted 2-3 times with 70%-80% industrial ethanol by reflux, and the extracts were combined and concentrated to obtain an extract. The extract was extracted with ethyl acetate and n-butanol successively. The ethyl acetate portion was gradient eluted with a dichloromethane-methanol system (100:1-1:1, v / v), and a total of 4 fractions (FrA-FrD) were collected.
[0008] (2) Fraction Fr.B was separated by HP20 column chromatography and eluted with ethanol and water gradient to obtain three fractions (Fr.B-1 to Fr.B-3).
[0009] (3) Fractions Fr.B-1 to Fr.B-3 were separated by ODS column (20:80-90:10, v / v) and eluted with ethanol-water gradient to collect 4 fractions (Fr.BI, Fr.B-II, Fr.B-III, Fr.B-IV).
[0010] (4) Fractions Fr.BI and Fr.B-II were gradient eluted with petroleum ether / ethyl acetate on a silica gel column. The eluted fraction Fr.BI-6 was subjected to preparative HPLC and eluted with methanol and water to obtain 9 fractions (Fr.BI-6-1 to Fr.
[0011] BI-6-9), Fr.BI-6-3 was subjected to semi-preparative HPLC chromatography and eluted with CH3CN-H2O to separate and purify compound 1. Fr.BI-6-5 was subjected to semi-preparative HPLC chromatography and eluted with MeOH / H2O to separate and purify compound 2 and compound 3. Fr.BI-6-8 was subjected to semi-preparative HPLC chromatography and eluted with CH3CN-H2O to separate and purify compound 4. The compounds were further chirally separated using a Daicel Chiralpak IG chiral chromatographic column, and n-hexane isopropanol system was used to separate and obtain compounds 1a / 1b-4a / 4b.
[0012] in:
[0013] The concentration of dichloromethane-methanol in step (1) is: 100:1, 50:1, 30:1, 20:1, 10:1, 1:1.
[0014] The concentration conditions of ethanol water in HP20 column chromatography in step (2) are: 30%, 60%, 90% (v / v).
[0015] In step (4), the ratio of petroleum ether / ethyl acetate is 100:1, 50:1, 30:1, 20:1, 10:1, 5:1, the ratio of preparative liquid phase methanol / water is 40:60, the ratio of semi-preparative liquid phase methanol / water is 25:75, and the ratio of semi-preparative liquid phase acetonitrile / water is 20:80.
[0016] During the chiral separation in step (4), the ratios of n-hexane to isopropanol are: 1:1 (1a / 1b), 2:1 (2a / 2b), 1:1 (3a / 3b), and 3:1 (4a / 4b).
[0017] The obtained compounds were systematically identified and the results are as follows:
[0018] The structures of compounds 1-4 were identified by high-resolution mass spectrometry, one-dimensional NMR, two-dimensional NMR, X-ray single crystal diffraction, computed NMR and ECD. The relevant spectra are attached. Figure 1-13 .
[0019] Compound 1 is a colorless oil (methanol) and is easily soluble in solvents such as methanol. HRESIMS gives a quasi-molecular ion peak of 579.2200 [M+Na] + (calcd for C 30 H 36 O 10 Na, 579.2201), the molecular weight of the compound was determined to be 556, and the molecular formula was C 30 H 36 O 10 , the calculated unsaturation is 13. 1 In the H NMR (600MHz, CD3OD) spectrum, two groups of 1,3,4-trisubstituted benzene ring proton signals δ H 6.86 (1H, d, J = 1.6 Hz), 6.62 (1H, overlapped), 6.63 (1H, overlapped), 6.71 (1H, d, J = 2.0 Hz), 6.80 (1H, d, J = 8.2 Hz), 6.59 (1H, dd, J = 8.2, 2.0 Hz), 3 oxygen-linked methine proton signals δ H 5.26 (1H, d, J = 2.3 Hz), 4.58 (1H, d, J = 2.5 Hz), 4.52 (1H, d, J = 7.7, 5.1, 2.5 Hz), 3 methoxy proton signals δ H 3.82(3H,s),3.66(3H,s),3.65(3H,s). 13 The C NMR (150 MHz, CD3OD) spectrum showed 30 carbon signals, including 18 benzene ring carbon signals, 4 methine carbon signals, 5 methylene carbon signals and 3 methoxy carbon signals.
[0020] Through comprehensive analysis of NMR data, it is inferred that there are three basic substructures of C6-C3 in the structure of the compound, A, B and C. H-7 is related to C-2 / C-6, H-8 to C-1, H-9 to C-7, and H-2 to C-4 / C-6 by HMBC. 1 H- 1 The H-7 / H-8 / H2-9 spin system in the H COSY spectrum confirmed the presence of fragment A in the structure. The HMBC correlations of H-2′ and C-7′, H-5′ and C-1′ / C-3′, and H-8′ and C-1′ were combined with 1 H- 1The H-7' / H-8' / H2-9' spin system in the H COSY spectrum suggests the presence of another C6-C3 unit (fragment B). The key HMBC correlations between H-8 and C-1', H-5' and C-8, and H-7 and C-7' indicate that A and B form a unique heterochromatic structure fragment through the C7-O-C7' bridge and C8-C6'. The HMBC correlation from H-8' to C-4" suggests that the last C6-C3 unit (fragment C) is connected through C8'-O-C4". The substitution positions of the three methoxy groups were also determined by HMBC correlation. The compound was assigned to carbon-hydrogen direct correlations by HSQC spectrum and combined with its 1 H- 1 The planar structure of the compound was determined by H COSY correlation.
[0021] The relative configuration of compound 1 was determined by NOESY spectroscopy combined with coupling constants and calculated NMR. In the NOESY spectrum, the key correlation between H2-9 and H-2 and the smaller coupling constant (J 7,8 =2.3Hz), the relative configuration of the C-7 and C-8 chiral centers can be determined. The NOESY correlation of H-7′ and H-2 shows that H-7 and H-7′ are in trans configuration. In addition, due to the presence of a freely rotatable flexible side chain fragment (C8′-C9′) in the structure, the relative configuration of the C8′ position cannot be determined by NOESY correlation signals and coupling constant analysis. Therefore, quantum chemical NMR chemical shift calculations were performed for its two possible configurations (7R*, 8R*, 7′R*, 8′S*)-1-A and (7R*, 8R*, 7′R*, 8′R*)-1-B, and the calculation results were analyzed in combination with DP4+ probability analysis. The results show that at the mPW1PW91 / 6-311+G(d,p) / / B3LYP / 6-31G(d) level, the calculated and measured NMR data of 1-A have a better fit (R 2 1-A =0.9980,R 2 1-B =0.9974), and its DP4+ probability analysis is close to 100%, so the relative configuration of C8′ position is determined to be S*.
[0022] Due to the absence of Cotton absorption in the ECD spectrum of the compound and the close approach to zero optical rotation value of the compound, it is inferred that the compound exists in the form of a racemic mixture. The compound was further separated using the chiral separation column Daicel Chiralpak IG to obtain a pair of enantiomers 1a and 1b, with a ratio close to 1:1. Their absolute configurations were determined by comparing the calculated ECD with the measured ECD. By comparison, it was found that the measured ECD curve of compound 1a was in good agreement with the calculated ECD curve of 7R, 8R, 7′R, 8′S configuration, thus determining that the absolute configuration of compound 1a was 7R, 8R, 7′R, 8′S, and the absolute configuration of 1b was 7S, 8S, 7′S, 8′R.
[0023] Compound 2 is a colorless oil (methanol). It is easily soluble in solvents such as methanol. HRESIMS gives a quasi-molecular ion peak of 445.1475 [M+Na] + (calcd for C 21 H 26 O9Na,445.1469), the molecular weight of the compound is determined to be 422, and the molecular formula is C 21 H 26 O9, the calculated unsaturation is 9. By comparing and comprehensively analyzing the NMR data of 2 and 1, it is found that they have similar structures, the difference is that 2 lacks a basic substructure of C6-C3 and has an additional methoxy group. In the HMBC spectrum, H-7 is correlated with C-2 / C-6 / C-7′, H-8 is correlated with C-1 / C-1′, H-5′ is correlated with C-8, and H-7′ is correlated with C-2′ / C-9′. 1 H- 1 The H-7 / H-8 / H2-9 and H-7' / H-8' / H2-9' spin systems in the H COSY spectrum further confirmed the structure of the compound, which also contained heterochromatic structural fragments formed by C7-O-C7' bridge and C8-C6'. The substitution positions of the three methoxy groups were determined by HMBC correlation. The compound was assigned to carbon-hydrogen direct correlation by HSQC spectrum and combined with its 1 H- 1 The planar structure of the compound was determined by H COSY correlation.
[0024] The relative configuration of compound 2 was determined similarly to that of compound 1. In 2, the key NOE correlation and coupling constant (J) of H-9 and H-2 were used to determine the relative configuration of compound 2. 7,8=5.0Hz), the relative configuration of C-7, C-8 chiral centers was determined. NOE correlation of H-7′ and H-2 showed that H-7 and H-7′ were in trans configuration. Since there is also a freely rotatable flexible side chain fragment (C8′-C9′) in this compound, the relative configuration of C8′ was determined to be R* using the same NMR calculation method as compound 1, and the DP4+ probability analysis of hydrocarbon data was 100.0%, thereby determining the relative configuration of the compound. Due to the absence of Cotton absorption in the ECD spectrum of the compound and the optical rotation value approaching zero, it is speculated that the compound exists in the form of a racemic mixture. The compound was further separated using the chiral separation column Daicel Chiralpak IG to obtain a pair of enantiomers 2a and 2b with a ratio close to 1:1. The absolute configurations of the two were determined by comparing the calculated and measured ECD methods. Through comparison, it was found that the measured ECD curve of compound 2a was in good agreement with the calculated ECD curves of 7R, 8R, 7′R, 8′R configurations. Therefore, the absolute configurations of compound 2a were determined to be 7R, 8R, 7′R, 8′R, and the absolute configurations of 2b were determined to be 7S, 8S, 7′S, 8′S.
[0025] Compound 3 is a colorless oil (methanol). It is easily soluble in solvents such as methanol. HRESIMS gives a quasi-molecular ion peak of 391.1389 [M–H] – (calcd for C 20 H 23 O8,391.1387), the molecular weight of the compound was determined to be 392 and the molecular formula was C 20 H 24 O8, the calculated unsaturation is 9. By comparing the NMR data of 3 and 2, it was found that they have the same parent nuclear structure, the difference is the lack of a methoxy signal in 3. The planar structure of 3 was further verified by HMBC spectrum. In the NOESY spectrum, it can be observed that H-7 is related to H-9, H-7 to H-6, and the large coupling constant (J) of H-7 and H-8 is 7,8=10.2Hz), it is speculated that H-7 and H-8 are in trans configuration; the NOE correlation between H-7′ and H-7 shows that H-7 and H-7′ are in cis configuration. In addition, the relative configuration of C8′ was determined to be R* by combining NMR calculation with DP4+ probability analysis, and its DP4+ probability analysis was 100.0%. The relative configuration of 3 was thus determined. Considering that the optical rotation value of the compound is close to zero and there is no obvious Cotton effect in the ECD curve, it is speculated that it is a racemic mixture. The compound was further separated using the chiral separation column Daicel Chiralpak IG to obtain a pair of enantiomers 3a and 3b with a ratio of 1:1. The absolute configuration of the two was determined by comparing the calculated and measured ECD methods, thereby determining that the absolute configuration of compound 3a is 7S, 8R, 7′R, 8′R, and the absolute configuration of 3b is 7R, 8S, 7′S, 8′S. In addition, single crystals of compound 3b were obtained in a mixed solvent (MeOH / H2O, 1:1) and single crystal X-ray diffraction experiments were performed using a Bruker D8 QUEST PHOTON II diffractometer (Cu Kα) (Flack constant was 0.06(7)), further verifying the absolute configurations of compounds 3a and 3b.
[0026] Table 1 Compound 1-2 1 H(600MHz) and 13 C (150 MHz) NMR data
[0027]
[0028]
[0029] Compound 4 is a colorless oil (methanol). It is easily soluble in solvents such as methanol. HRESIMS gives a quasi-molecular ion peak of 355.1152 [M+Na] + (calcd for C 18 H 20 O6Na,355.1152), the molecular weight of the compound is determined to be 332, and the molecular formula is C 18 H 20 O6, the calculated unsaturation is 9. By comparing the NMR data of 4 and 3, it was found that 4 and 3 have similar parent core structures, the difference is that there are two carbons missing at the C-7′ position in 4, so C-7′ is a typical oxymethylene carbon. The planar structure of 4 was further determined by HMBC correlation. Its relative configuration was determined by NOESY correlation, the NOE correlation of H-7 with H-9, H-7 with H-6, combined with the larger coupling constant (J) of H-7 and H-8. 7,8=6.8Hz), indicating that H-7 and H-8 were in trans configuration. The compound was further separated using a chiral separation column Daicel Chiralpak IG to obtain a pair of enantiomers 4a and 4b. By comparing the calculated ECD with the measured ECD, the absolute configurations of 4a and 4b were determined to be 7S, 8R and 7R, 8S, respectively.
[0030] Table 2 Compound 3-4 1 H(600MHz) and 13 C (150 MHz) NMR data
[0031]
[0032]
[0033] The neuroprotective activity of the four pairs of new lignan derivatives of the present invention was evaluated. The results showed that compounds 2a and 3a / 3b showed better neuroprotective activity than the positive drugs. Therefore, the new lignan derivatives of the present invention have the potential to be clinical neuroprotective drugs.
[0034] The advantages of the present invention are that the compounds are all new compounds with novel structures, and are all optically pure compounds with definite stereo configurations. They also have good activity and are worth further development. BRIEF DESCRIPTION OF THE DRAWINGS
[0035] Figure 1 UV spectrum of compound 1;
[0036] Figure 2 HRESIMS spectrum of compound 1;
[0037] Figure 3 UV spectrum of compound 2;
[0038] Figure 4 HRESIMS spectrum of compound 2;
[0039] Figure 5 UV spectrum of compound 3;
[0040] Figure 6 HRESIMS spectrum of compound 3;
[0041] Figure 7 UV spectrum of compound 4;
[0042] Figure 8 HRESIMS spectrum of compound 4;
[0043] Fig. 9 Key HMBC correlation and COSY correlation of compounds 1-4;
[0044] Fig.10 Key NOESY correlation of compounds 1-4;
[0045] Fig.11 Single crystal image of compound 3;
[0046] Fig.12 Linear correlation plot of measured and calculated carbon chemical shifts of compounds 1-3;
[0047] Fig.13 Comparison of measured and calculated ECDs of compounds 1a / 1b-4a / 4b;
[0048] Fig.14 Protective activity of compounds 1a / 1b-4a / 4b against hydrogen peroxide-induced SH-SY5Y neuroblastoma cells. DETAILED DESCRIPTION
[0049] The following examples are intended to help those skilled in the art to better understand the present invention, but are not intended to limit the present invention in any way.
[0050] Example 1 Preparation of New Lignan Derivatives 1a / 1b-4a / 4b from Hawthorn
[0051] Take dried hawthorn (50kg) and extract it with 75% industrial ethanol by reflux for 2-3 times, combine the extracts and concentrate to obtain an extract. The obtained extract is extracted with ethyl acetate and n-butanol successively. The ethyl acetate part (500g) is subjected to silica gel column chromatography and gradient elution with dichloromethane-methanol system, and a total of 4 fractions (FrA~Fr D) are collected. Fraction Fr.B (90g) is separated by HP20 column chromatography and gradient eluted with ethanol and water to obtain 3 fractions (Fr.B-1~Fr.B-3). Fractions Fr.B-1~Fr.B-3 are separated by ODS column and gradient eluted with ethanol and water to obtain 4 fractions (Fr.BI, Fr.B-II, Fr.B-III, Fr.B-IV). The fractions Fr.BI (12 g) and Fr.B-II (10 g) were passed through a silica gel column and eluted with a petroleum ether / ethyl acetate gradient. The eluted fraction Fr.BI-6 was subjected to preparative HPLC and eluted with methanol water to obtain 9 fractions (Fr.BI-6-1 to Fr.BI-6-9). Fr.BI-6-3 was further subjected to semi-preparative HPLC chromatography and eluted with CH3CN-H2O to separate and purify compound 1 (4 mg). Fr.BI-6-5 was subjected to semi-preparative HPLC chromatography and eluted with MeOH-H2O to separate and purify compound 2 (2.2 mg) and compound 3 (4.2 mg). Fr.BI-6-8 was further subjected to semi-preparative HPLC chromatography and eluted with CH3CN-H2O to separate and purify compound 4 (4 mg). The compound was further subjected to chiral separation using a Daicel Chiralpak IG chiral chromatographic column and a n-hexane isopropanol system to obtain compounds 1a (1.0 mg), 1b (1.2 mg), 2a (0.8 mg), 2b (1.0 mg), 3a (2.0 mg), 3b (1.5 mg), 4a (1.1 mg), and 4b (1.3 mg).
[0052] Example 2 Neuroprotective activity of new lignan compounds 1a / 1b-4a / 4b from hawthorn
[0053] Human neuroblastoma SH-SY5Y cells in the logarithmic growth phase were cultured at a density of 1.5×10 5Cells were inoculated into 96-well plates at 100 μg / well and incubated in an incubator at 37°C and 5% CO2 for 12 hours until the cells adhered to the wall. Blank control group: No H2O2 and compounds were added, and the cells were cultured as above. H2O2 group (model group): Only H2O2 was added to treat the cells. Drug administration group: Compounds 1a / 1b-4a / 4b (12.5, 25, 50 μM) were added to the culture medium and incubated for 1 hour, and H2O2 (200 μmol / L) was added to each well for reaction for 4 hours. Positive control group: The positive drug Troxol (12.5, 25, 50 μM) was added to the culture medium and incubated for 1 hour, and H2O2 (200 μmol / L) was added to each well for reaction for 4 hours. Survival rate (%) = [A 490 (Administration group)-A 490 (blank control)] / [A 490 (Negative control)-A 490 (blank control)]×100%.
[0054] All experiments were repeated three times in parallel and analyzed using GraphPad Prism 6 software. The results of the drug-treated group and the model group were statistically analyzed using t-test. The results are shown in Fig.14 As shown, compared with the positive drugs, compounds 2a, 3a and 3b showed significant cell protection activity at different concentrations, among which 3a had a cell survival rate of 87.24±1.01% and 87.00±1.41% at concentrations of 12.5μM and 25μM.
Claims
1. A method for preparing a novel lignan derivative having an isochroman fragment and having an anti-neurodegenerative disease effect, Features: The structure of the new lignan derivative is shown below: , the preparation method comprises the following steps: (1) Dried hawthorn fruit was extracted with industrial ethanol for 2-3 times by reflux, and the extracts were combined and concentrated to obtain an extract. The extract was extracted with ethyl acetate and n-butanol successively. The ethyl acetate fraction was subjected to silica gel column chromatography and gradient eluted with a dichloromethane-methanol system at a ratio of 100:1-1:
1. A total of 4 fractions Fr A to Fr D were collected; (2) The fraction Fr. B was separated by HP20 column chromatography and eluted with ethanol and water gradient to obtain three fractions Fr. B-1 to Fr. B-3; (3) The fractions Fr. B-1 to Fr. B-3 were separated by ODS column and eluted with ethanol-water gradient to obtain four fractions Fr. BI, Fr. B-II, Fr. B-III, and Fr. B-IV; (4) Fractions Fr. BI and Fr. B-II were subjected to gradient elution on a silica gel column using petroleum ether / ethyl acetate as the eluent. The eluted fraction Fr. BI-6 was subjected to preparative HPLC and eluted with methanol and water to obtain 9 fractions Fr. BI-6-1 to Fr. BI-6-9. Fr. BI-6-5 was subjected to semi-preparative HPLC and eluted with MeOH-H 2 O was used for elution, and compound 2 and compound 3 were separated and purified. The compounds were further chirally separated using a Daicel Chiralpak IG chiral chromatographic column, and compound 2a, compound 3a, and compound 3b were separated using an n-hexane isopropanol system.
2. The method for preparing the new lignan derivatives according to claim 1, It is characterized in that In the step (1), the hawthorn refers to hawthorn of the genus Crataegus in the family Rosaceae ( Crataegus pinnatifida ); The dried fruits of hawthorn were extracted with 70%-80% industrial ethanol by reflux.
3. The method for preparing the new lignan derivatives according to claim 1, It is characterized in that In the step (2), the fraction Fr. B was subjected to HP20 column chromatography to ethanol water v / v Gradient elution was performed with a ratio of 30%, 60%, and 90%.
4. The method for preparing the new lignan derivatives according to claim 1, It is characterized in that In step (3), the concentration of ethanol water in the ODS column chromatography is 20:80-90:
10. v / v .
